LIXT icon

Lixte Biotechnology
LIXT

Overview Fund Activity

8 hedge funds and large institutions have $4.39M invested in Lixte Biotechnology in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

Holders
8
Holders Change
+5
Holders Change %
+166.67%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AIP
1
Almanack Investment Partners
Pennsylvania
$3.43M
2
SM
2
Sabby Management
Florida
$262K
3
Citadel Advisors
3
Citadel Advisors
Florida
$79K
4
Morgan Stanley
4
Morgan Stanley
New York
$69K
5
TRCT
5
Tower Research Capital (TRC)
New York
$5K

Top Sellers

1
AFM
1
Anson Funds Management
Texas
$0
2
UBS Group
2
UBS Group
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AIP
1
Almanack Investment Partners
Pennsylvania
$3.43M 1,042,105 +1,042,105 New
SMP
2
Santa Monica Partners
Florida
$548K 166,667 – –
SM
3
Sabby Management
Florida
$262K 79,735 +79,735 New
Citadel Advisors
4
Citadel Advisors
Florida
$79K 23,813 +23,813 New
Morgan Stanley
5
Morgan Stanley
New York
$69K 21,053 +21,053 New
TRCT
6
Tower Research Capital (TRC)
New York
$5K 1,574 +1,574 New
BlackRock
7
BlackRock
New York
$1K 303 +303 New
AFM
8
Anson Funds Management
Texas
– – -57,106 Closed
UBS Group
9
UBS Group
Switzerland
– – -1,683 Closed
CFGS
10
Concourse Financial Group Securities
Alabama
– – – –
Wells Fargo
11
Wells Fargo
California
$0 16 +16 New